At a glance
ClinicalIndex Comparison RecordN/ACompleted· 211 enrolled
Drug / intervention
Liposomal bupivacaine +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Efficacy of Liposomal Bupivacaine Versus Standard Analgesia in Pain Management of Total Joint Arthroplasty
In Brief
A clinical study evaluating Liposomal bupivacaine and Standard of care analgesia for Osteoarthritis, Knee and 2 related conditions. Completed, enrolled 211 participants across 1 site.
Detailed Summary
The purpose of this study is to determine whether liposomal bupivacaine is effective in the management of pain following total joint arthroplasty, as compared to standard of care analgesia.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
201520162017201820192020202120222023202420252026
Enrollment StartJul 2014
First PostedJul 2014
Primary CompletionSep 2015
Study CompletionOct 2015
TodayJul 2026
First PostedJul 22, 2014
Enrollment StartJul 1, 2014
Primary CompletionSep 1, 2015
Study CompletionOct 1, 2015
TodayJul 2, 2026
Enrollment to primary: 1.2 yearsPosted 11.9 years ago
Interventions
Liposomal bupivacainedrug
Standard of care analgesiadrug